Europe Grants CRISPR-Cas9 Patent to CalyxtDecember 19, 2018
A patent has been issued by the European Patent Office to Calyxt, Inc. which gives them permission to create gene-edited plants by the transient delivery of sequence-specific nucleases, including CRISPR-Cas9.
"Conventionally, gene editing is performed by delivering DNA to cells," says Dr. Dan Voytas, Calyxt's Chief Science Officer and University of Minnesota Professor. "The DNA encodes a nuclease, such as CRISPR-Cas9, which makes the gene edit. The problem with conventional gene editing is that DNA can integrate randomly into the genome, creating off-target effects. For example, genes can be disrupted by the incoming DNA that you didn't intend to disrupt. Calyxt has accomplished a precise method of gene editing that creates plants with the desired traits."Calyxt has been using TALEN® in developing better food products, but the company is continuously trying out new gene editing technologies and approaches to edit plant genes. Calyxt's intellectual property portfolio is also strengthened by having licensed from Cellectis two patents of a family claiming the uses of chimeric nucleases, such as TALEN® and CRISPR-Cas9, for gene editing in any type of cells.
Read the media release from Calyxt.
See more articles:
News from Around the World
- Multidisciplinary Study Traces Movement of Maize in South America
- Rwandan Women in Biosciences Embrace Science Communication
- Iowa State University Study Says Anti-GMO Sentiment Has Repercussions for Developing World
- Scientists Discover Way to Make Rice Plants Replicate through Seeds as Clones
- Australian OGTR Receives License Application for Field Trial of GM Chickpea
- Japan May Allow Genome-edited Food Sale
- Plants Don't Like to be Touched, Study Finds
- Stockholm University Scientists Discover Gene that Helps Submerged Plants
- Research Reveals MON 810 and NK603 GM Maize Have No Effects on Rat Health or Metabolism
- Study Shows Inheritance of Transgenes in Bt Cotton Lines Resistant to Bollworm
Plant Breeding Innovations
- Europe Grants CRISPR-Cas9 Patent to Calyxt
- CRISPR-Cas9 Used in Breeding Indica Glutinous CMS Line WX209A
Beyond Crop Biotech
- GM Pigs Resist Infection from Classical Swine Fever Virus
- Revised ISAAA Infographics: 22 Years of Biotech Crops in the World
- Talking Biotech: How Do We Get Consumers to Think Like Scientists?
Subscribe to CBU: